189 related articles for article (PubMed ID: 20592727)
1. Multiplicity adjustment big and small in clinical studies.
Hsu JC
Clin Pharmacol Ther; 2010 Aug; 88(2):251-4. PubMed ID: 20592727
[No Abstract] [Full Text] [Related]
2. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 2: statistical concepts in study design and analysis.
Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
Circulation; 2004 Jun; 109(21):e305-7. PubMed ID: 15173053
[No Abstract] [Full Text] [Related]
3. Qualitative consistency of treatment effects in multiregional clinical trials.
Tanaka Y; Li G; Wang Y; Chen J
J Biopharm Stat; 2012 Sep; 22(5):988-1000. PubMed ID: 22946945
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials with allergen products--statistical considerations.
Volkers P
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2006; (95):172-80; discussion 181. PubMed ID: 17393737
[No Abstract] [Full Text] [Related]
5. The clinical significance of statistical significance.
Kane RC
Oncologist; 2008 Nov; 13(11):1129-33. PubMed ID: 18984874
[TBL] [Abstract][Full Text] [Related]
6. A review of the limitations of statistical analysis of treatment outcomes used in periodontal research.
Galgut PN
J Int Acad Periodontol; 2003 Oct; 5(4):92-7. PubMed ID: 14604057
[TBL] [Abstract][Full Text] [Related]
7. How to deal with multiple endpoints in clinical trials.
Neuhäuser M
Fundam Clin Pharmacol; 2006 Dec; 20(6):515-23. PubMed ID: 17109645
[TBL] [Abstract][Full Text] [Related]
8. The influence of age on sample size calculation in acute pain trials using morphine consumption as an end point.
Reeves M
Anesth Analg; 2010 Apr; 110(4):1186-90. PubMed ID: 20142341
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity and flexibility in clinical trials.
Brannath W; Koenig F; Bauer P
Pharm Stat; 2007; 6(3):205-16. PubMed ID: 17674349
[TBL] [Abstract][Full Text] [Related]
10. [Multiplicity of inferences in clinical trials: adjustment methods, clinical interpretation issues].
Jouan-Flahault C; Casset-Semanaz F; Minini P
Med Sci (Paris); 2004 Feb; 20(2):231-5. PubMed ID: 14997445
[TBL] [Abstract][Full Text] [Related]
11. Design of the "Thorough QT Study".
Darpo B; Sager P
Clin Pharmacol Ther; 2008 Apr; 83(4):529; author reply 530. PubMed ID: 18043696
[No Abstract] [Full Text] [Related]
12. The clinician as investigator: participating in clinical trials in the practice setting: Appendix 1: fundamentals of study design.
Lader EW; Cannon CP; Ohman EM; Newby LK; Sulmasy DP; Barst RJ; Fair JM; Flather M; Freedman JE; Frye RL; Hand MM; Jesse RL; Van de Werf F; Costa F;
Circulation; 2004 Jun; 109(21):e302-4. PubMed ID: 15173052
[No Abstract] [Full Text] [Related]
13. Sample size determination for the false discovery rate.
Pounds S; Cheng C
Bioinformatics; 2005 Dec; 21(23):4263-71. PubMed ID: 16204346
[TBL] [Abstract][Full Text] [Related]
14. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
15. Intravenous immunoglobulin in relapsing-remitting multiple sclerosis: a dose-finding trial.
Khan OA; Tselis A; Boster A
Neurology; 2009 Jun; 72(24):2134; author reply 2134-5. PubMed ID: 19528523
[No Abstract] [Full Text] [Related]
16. Blinded sample size reestimation with count data: methods and applications in multiple sclerosis.
Friede T; Schmidli H
Stat Med; 2010 May; 29(10):1145-56. PubMed ID: 20146203
[TBL] [Abstract][Full Text] [Related]
17. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
Kong L; Kohberger RC; Koch GG
J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
[TBL] [Abstract][Full Text] [Related]
18. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
19. [Analysis and importance of statistical power and sample size in empirical scientific research].
Klimek KM
Wiad Lek; 2008; 61(7-9):211-5. PubMed ID: 19172834
[TBL] [Abstract][Full Text] [Related]
20. Analysis of a binary composite endpoint with missing data in components.
Quan H; Zhang D; Zhang J; Devlamynck L
Stat Med; 2007 Nov; 26(26):4703-18. PubMed ID: 17431851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
